INM - InMed Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

InMed Pharmaceuticals's activity chart (see below) currently has 2 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from ALLIANCE GLOBAL PARTNERS on 16-May-2022. First documented stock forecast 14-May-2021.

Raghuram Selvaraju Scott Henry

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-May-2021

$200000

$199998.45 (12986913.00%)

$2875000

4 years 1 months 27 days ago
(16-May-2022)

0/2 (0%)

$199600 (49900.00%)

Buy

$150

$149.41 (25323.73%)

4 years 7 months 12 days ago
(01-Dec-2021)

0/1 (0%)

$109.25 (268.10%)

Show more analysts

What is INM (InMed Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INM (InMed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju has 39 price targets and 32 ratings on INM

Which analyst is the currently most bullish on INM (InMed Pharmaceuticals)?

Scott Henry with highest potential upside - $199998.45

Which analyst is the currently most reserved on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju with lowest potential downside - $149.41